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Abstract 15 
The integration of surface enhanced Raman scattering (SERS) with droplet microfluidics has the 16 
potential to improve our understanding of cellular systems. Herein, we present the first 17 
application of SERS droplet microfluidics for single cell analysis. A microfluidic device was 18 
used to encapsulate single prostate cancer cells and wheat germ agglutin (WGA) functionalized 19 
SERS nanoprobes in water-in-oil droplets that were subsequently locked into a storage droplet 20 
array for spectroscopic investigation. The stationary droplets enabled the rapid identification of 21 
SERS regions of interest in live cancer cells by allowing collection of “fast” coarse maps over an 22 
area of several mm2 followed by “slower” detailed interrogation of the identified hotspots. We 23 
demonstrate SERS at cellular resolution via a proof-of-concept assay that detects glycan 24 
expression on the surface of prostate cancer cells using WGA modified metallic nanoparticles.  25 
The data illustrates the potential of SERS optofluidic systems for high-throughput cell screening 26 
and illustrates a previously unobserved high degree of cell-to-cell variability in the size and 27 
number of glycan islands. 28 
  29 
Introduction  30 
Over the past decade, it has become increasingly clear that the genetic and phenotypic 31 
characterization of cell populations at the single cell level is a key consideration of fundamental 32 
biology research and cell screening. Single-cell droplet microfluidics, combining microfluidic 33 
technologies with analytical spectroscopies, presents an exciting opportunity to understand cell-34 
to-cell variability. Significant developments have been made in single-cell -omics1-3 to the point 35 
that digital droplet polymerase chain reaction (ddPCR) instruments are now commercially 36 
available. A smaller fraction of the literature has focused on analyzing the behavior of single 37 
cells encapsulated in droplets, from metabolite profiling4 to growth monitoring.5 Droplet 38 
microfluidics enables the production of thousands of individual microreactors in the form of 39 
surfactant stabilized emulsions, which are not subject to ‘memory effects’ or the adhesion of 40 
colloid/analyte conjugates within the microfluidic device.6 The generation of nano- to femto-liter 41 
droplets for live cell studies is typically achieved by entraining aqueous droplets in 42 
perfluorochemical (PFC) oils that have a very high gas solubility and thus allow for oxygen 43 
exchange.7 Past studies have shown that organisms can be kept alive in droplets for several 44 
days.8   45 
Surface enhanced Raman scattering (SERS) is a well-established technique that can be 46 
used for the detection of trace levels of metals, toxins, pesticides, DNA, proteins, pathogens, and 47 
eukaryotic cells.9-16 SERS is particularly well suited for bioanalytical applications because it is 48 
non-destructive and non-invasive and it provides high molecular specificity and spatial 49 
resolution.17 Importantly, fresh tissues and cells can be interrogated with minimal prior 50 
preparation because of the weak Raman signal of water molecules.18 Additionally, SERS has 51 
nearly infinite multiplexing capacity and, unlike fluorescence, tag degradation is not a concern.19 52 
The integration of SERS with droplet microfluidics has been demonstrated for the  detection of 53 
crystal violet,20  potassium ferricyanide,21 the pharmaceuticals promethazine and mitoxantrone,22 54 
Escherichia coli,23 Staphylococcus aureus,24 and eukaryotic cell lysate.25 Using online 55 
interrogation (i.e., the collection of SERS spectra from moving droplets), these applications 56 
achieved very high-throughput, but collected only one or two spectra per droplet. A benefit of 57 
using SERS that was not exploited in these prior studies is the production of high resolution 58 
maps. To that end, a different implementation of droplet microfluidics, as popularized by the 59 
dropspot device,26 was used whereby a chamber array was used to keep isolated droplets 60 
stationary during SERS interrogation.  61 
In this study, we combine droplet microfluidics with SERS to study cell-to-cell and 62 
intracellular variability in the expression of glycans on the cell membrane. Cell membrane 63 
carbohydrates are an important oncology target27 because their overexpression by cancerous 64 
cells, relative to healthy cells, can provide an early indication of cancer.  Previously, we 65 
demonstrated that the glycan N-acetyl neuraminic (sialic) acid expressed by cancerous prostate 66 
(PC3) cells can be targeted using the lectin wheat germ agglutinin (WGA).10 This glycan 67 
detection assay was selected for three main reasons: first, the sialic acid residues (target) are 68 
abundant on the cell membrane; second, the attachment of the recognition element (lectin) to 69 
gold nanoparticles via streptavidin-biotin chemistry is a robust and rapid functionalization 70 
method; and, finally, the use of a reporter molecule underscores the potential of this technique to 71 
be used for multiplex detection.  The use of an established assay allowed us to focus this study 72 
on the development of an integrated microfluidic system and the associated analysis algorithms. 73 
The two major outcomes of this work are the demonstration of the ability to probe the contents 74 
of stationary droplets over a variety of scales and the first application of whole cell imaging 75 
using SERS microfluidics.   76 
Materials and Methods  77 
Device Design and Preparation.  Microfluidic devices were fabricated using standard photo- 78 
and soft-lithography techniques, as previously described.28 Briefly, master templates with a final 79 
resist thickness of 50 μm were produced on silicon wafers using SU8 photoresist (3000 series, 80 
MicroChem, US) following the manufacturer's protocol. The resist was exposed through a 81 
photomask (JD Photo-Tools, UK) to UV light and was developed in Micro-Posit EC solvent 82 
(Rohm and Haas, US). Finally, the wafer surface was silanized by vapor deposition of 83 
1H,1H,2H,2H-perfluorooctyltrichlorosilane (Sigma Aldrich, UK) for 1 hour.  84 
Polydimethylsiloxane (PDMS) was poured onto the silicon master at a 10:1 (w:w) ratio of base 85 
to curing agent, degassed in a vacuum desiccator chamber, and cured at 80 °C for at least 2 86 
hours. The PDMS devices were then peeled from the mold, cut to the desired size, and holes 87 
were punched using 1 mm biopsy punches to obtain inlet and outlet ports. Devices were cleaned 88 
and irreversibly bonded to glass microscope slides using oxygen plasma and subsequently treated 89 
with undiluted Aquapel (PPG Industries) to obtain fluorophilic microchannel surfaces. 90 
Nanoparticle Synthesis and Functionalization. Sodium citrate (final concentration 3.88 91 
mM) was added to 100 mL of boiling 1 mM tetrachloroauric acid under vigorous mixing 92 
conditions. The reaction was allowed to run until the solution color changed to wine red, 93 
indicating completion. Gold nanoparticles were functionalized in 5 mL batches and were pH 94 
adjusted to circumneutral using 0.1 M potassium carbonate. Next, 2 µM of malachite green 95 
isothiocyanate (MGITC), a strong SERS dye with a distinct finger print, was used to pre-96 
aggregate gold colloid. The colloid was coated with 0.1 mg/mL streptavidin, and it was then 97 
mixed with 2% BSA to quench further aggregation. After > 30 minutes, the colloid was 98 
centrifuged and biotin functionalized wheat germ agglutinin (WGA; Sigma-Aldrich, UK) was 99 
added to the nanoparticle pellet at a concentration of 0.17 mg per mL colloid. Following 100 
overnight incubation, the nanoprobes were washed three times with 1% BSA in PBS. The local 101 
surface plasmon resonance (LSPR) of the probes was between 530 nm and 533 nm as 102 
determined by UV-vis and the particle size (z-average) of the probes in 1% BSA was ~130 nm 103 
with a polydispersity index between 0.5 and 0.6 as determined by dynamic light scattering 104 
(Malvern Nano-ZS, Malvern, UK). 105 
Cell Preparation. Tumourigenic (PC-3) human prostate epithelial cell lines were 106 
cultured in RPMI 1640 Medium supplemented with HEPES, 10% fetal calf serum, 1% penicillin, 107 
1% streptomycin, and 1% fungizone (Gibco, UK). Cells were grown to confluence in an 108 
incubator at 37 °C with 5% CO2 and then harvested with trypsin/EDTA. Solutions containing 10
6 109 
cells/mL were used for microfluidic experiments to favor single cell encapsulation events. The 110 
Poisson distribution dictates that in passive cell encapsulation the majority of droplets generated 111 
are empty with between 5% to 37% of the droplets containing cells.29   112 
Device Loading. Microfluidic devices were connected to 1 mL syringes via 113 
polytetrafluoroethylene (PTFE) tubing (Cole Parmer). Syringe pumps were used to vary the fluid 114 
flow rates between 0.16 and 0.21 mL/hour to produce droplets of the appropriate size at the T-115 
junction.  The continuous phase was FC-40 (3M Company) fluorinated oil with 2 wt% block 116 
copolymer fluorosurfactant (designed by the Weitz Group at Harvard and supplied by RAN 117 
Biotechnologies, catalogue# 008-FluoroSurfactant, Beverly, MA, USA). The dispersed phase 118 
was a solution of phosphate buffered saline (PBS) or phenol-free media containing cells that had 119 
been incubated with nanoprobes and subsequently washed.  120 
SERS Spectroscopy. Two different instruments were used to collect data. All glycan 121 
island data was collected with an inverted Renishaw InVia system (Renishaw, Wolton-under-122 
Edge, UK) employing a 633 nm wavelength excitation laser, 1200 g/mm grating, 20× objective 123 
(N.A. 0.40) with incident power of 1 mW and a 0.1 second per pixel collection time.  SERS at 124 
scale data was also collected with the same Renishaw instrument and a WITec Alpha 300R 125 
confocal microscope (WITec, Ulm, Germany) in an upright set-up employing a 633 nm 126 
wavelength excitation laser and a 300 g/mm. The SERS at scale data was collected at several 127 
different magnification and collection times as outlined in the test. The details of the objectives 128 
use can be found in Table S1.  129 
SERS Processing. A data processing tool was developed in Matlab to process Raman or 130 
SERS spectra in the SPC file format. Briefly, spectra were baseline corrected using an 131 
asymmetric least squares baseline correction.30 A peak or peaks of interest were then specified 132 
and the intensity of the peaks was automatically extracted from the dataset. For data collected in 133 
a rastering format (maps) the intensity at each point could be plotted to generate SERS maps.    134 
Results and Discussion 135 
To interrogate single cells within polydimethylsiloxane (PDMS) microfluidic devices 136 
using SERS, a laser must pass through four media (Fig 1A) before interacting with the sample. 137 
Malachite green isothiocyanate (MGITC) was selected as the Raman reporter because its 138 
signature peaks at 1614 cm-1 and 1364 cm-1, assigned to the phenyl-N + C−C stretching mode 139 
and the phenyl-N stretching mode31, do not overlap with the strong PDMS asymmetric and 140 
symmetric C-H stretches at 2965 cm-1 and 2903 cm-1 respectively32-34 (Fig 1A). Gold 141 
nanoparticles (35 nm) were pre-aggregated with MGITC, coated with streptavidin, mixed with 142 
biotinylated wheat germ agglutinin (WGA) and then washed to remove unbound WGA. 143 
Adherent PC3 cells were removed from the culture flask to create a cell suspension, incubated 144 
with the nanoprobes for 10 minutes, washed to remove unbound nanoprobes and ultimately 145 
encapsulated in droplets. The droplets were subsequently stored in a chamber array, a modified 146 
version of the dropspot device26,  before the device was transferred for imaging by Raman 147 
microscopy.   148 
SERS data of biological samples is often acquired by defining a region of interest over 149 
which the laser is rastered. At each pixel location a spectrum is collected, from each spectrum the 150 
same feature (i.e., wavenumber or wavenumber range) is selected, and the value (i.e., intensity or 151 
integrated intensity) of the feature is then plotted on an x-y grid to generate a SERS map. 152 
Commonly, conclusions are drawn by manually inspecting SERS maps, but the use of statistical 153 
descriptions and chemometric analyses are becoming a standard part of SERS data analysis. 154 
Often these higher order descriptions, such as in our work on intracellular pH35 detection, are 155 
accompanied with re-rendered SERS maps that display complex content. However, variability 156 
between maps or the physical clustering of regions of interest (i.e., how many pixels that meet a 157 
certain criterion are adjacent to one another) is not taken into account. While not appropriate for 158 
all experiments, the study of cell expression, especially as enabled by droplet microfluidics, 159 
supports the adoption of automated techniques to detect regions of interest. The imaging 160 
processing techniques developed in our data tool allow us to generate SERS maps, to then 161 
identify regions of interest within each map, and to then statistically analyze the size and 162 
distribution of each region.  163 
Development of Data Processing and Analysis Tool.  164 
A workflow diagram illustrating our data processing algorithm is shown in Figure 2. SERS maps 165 
enable visualization of the results of a SERS experiment and are a simplification of the total data 166 
collected (i.e., a reduction in data dimensionality). Embedded within each pixel of a SERS map 167 
is a full spectrum containing 1015 (Wire 4.2) or 1024 (Project FOUR 4.1) points and a myriad of 168 
vibrational information. A typical SERS map obtained for the single cell studies contained 900 169 
pixels or a total of 9 × 105 points. Baseline correcting, normalizing, and rendering a SERS map 170 
 Figure 1. Illustration of a single cell encapsulation event within the microfluidic device. The four media that the laser must 
pass through before interacting with the target (cancer cell) are labeled from i to iv. The cartoon also includes the dimensions 
of the microfluidic device and cancer cell. The inset displays the PDMS Raman spectrum through a droplet in the absence of 
nanoprobes or cells and the SERS spectra from Wheat Germ Agglutinin (WGA) functionalized nanoprobes (A). Zoom in of 
the cell membrane shows the expression of sialic acid. A WGA functionalized nanoprobe is shown attached to the sialic acid 
and the individual components of the probe are named (B).  
 
based on the intensity of a specific peak can be readily achieved using proprietary software such 171 
as Wire 4.2 or Project FOUR 4.1. However, these programs generally lack batch processing 172 
capacity, transparency in the data processing algorithms, and the ability to open data files in a 173 
non-proprietary format. To overcome these challenges and to take advantage of the large amount 174 
of information available from the SERS optofluidic platform a specialized data analysis and 175 
processing tool was written in Matlab. The code is available online at GitHub36.    176 
To optimize data handling and cross-platform functionality, we exported data from Wire 177 
4.2 or Project Four 4.1 using the SPC file format (.spc). This data was then imported into Matlab 178 
for further processing. .spc is preferred over text (.txt) or comma separated value (.csv) files 179 
because it contains the raw spectral plus metadata containing additional scan details. Within 180 
Matlab, automated baseline correction was achieved using a modification of Eiler’s asymmetric 181 
least squares baseline estimation.30 Following normalization, SERS maps could be rendered 182 
based on the intensity of a specific peak, the ratio of multiple peaks, or based on the 183 
mathematical transformation of a peak ratio.35 To demonstrate the efficacy of this data 184 
processing tool, data from a single experiment was processed using the tool and the Wire 4.2 185 
proprietary software (Fig S2).  Collected data was baseline corrected, the intensity of the 1609 186 
cm-1 peak was plotted (feature selection) and the maps were scaled using the same look-up-table 187 
(LUT) so that they could be directly compared. The resulting maps from the data processing tool 188 
and Wire 4.2 were identical. A spectrum to spectrum comparison of the data from a single pixel 189 
(Figure S2C & S2D) shows that the baseline corrected data is nearly identical, as would be 190 
expected from using distinct algorithms.  191 
The advantages of using this automated tool are evident when processing and analyzing a 192 
large number of analyses from an experiment or dataset (i.e., the collection of SERS maps 193 
collected from a single microfluidic device). The characteristics of each map, such as the 194 
minimum, maximum, and average pixel values, can be collated during processing and can be 195 
queried after all the data was processed to define a LUT. The maps can then be rescaled based on 196 
these statistics. For example, in our study of cell-to-cell heterogeneity (discussed vide infra) the 197 
LUT was defined to be 2× to 3× the standard deviation above the mean. Other variable ranges 198 
can be readily defined depending on the desired application. The library of SERS maps were 199 
analyzed and edge finding scripts were used to identify regions of interest and the size of clusters 200 
meeting certain criteria were calculated.  201 
SERS Whole Cell Imaging and observation of cell-to-cell heterogeneity.   202 
To demonstrate the capacity of the optofluidic platform for single cell analysis, wheat germ 203 
agglutin (WGA) was used to target the glycan N-acetyl neuraminic (sialic) acid expressed on 204 
cancerous prostate (PC3) cells. Pre-aggregated SERS hotspots coated with WGA – nanoprobes – 205 
were mixed, in excess, with PC3 cells, after a ten-minute incubation period the cells were 206 
washed to remove unbound nanoprobes and introduced into the microfluidic platform. A Poisson 207 
distribution for cell encapsulation in droplets was considered. A cell loading concentration of 106 208 
cells per mL favored the formation of single cell encapsulation events.29 SERS maps were then 209 
collected from: i) individual droplets with a focus on single cell encapsulation events, 210 
representative images shown in Figure 3A-C; and ii) multiple droplets (discussed in the next 211 
section). 212 
The raw data for each experiment was imported into the data processing software, 213 
 
Figure 2. Details of SERS scan: 20× Objective; 40µm by 40µm area of interest; pixel size 1µm/pixel; grating 1200g/mm; 
633nm laser; collection time 0.1 seconds. (A) At each pixel a spectrum is collected in two dimensions: intensity vs 
wavenumber. Pre-processing such as baseline correction and normalization are undertaken followed by feature selection. (B) 
Single SERS maps are rendered after feature selection to aid in data interpretation. At each x-y coordinate the intensity of the 
feature is depicted using a color (C). A library of maps is generated and increases the dimensionality to 4D (map × x location 
× y location × wavenumber) or after feature selection, fixing the wavenumber, 3D (map × x location × y location). Typical 
SERS data processing only discusses pixel intensity and uses measures such as mean intensity, standard deviation, etc. to 
describe the data set. For analysis of cells and other ordered objects crucial information is lost by neglecting pixel order (D1). 
Corrected total intensity (CTI) is a simple method that values pixel order.  The area of interest is selected, blue circle, and the 
integrated density of the area is calculated (area × mean intensity).  From this value, the mean background intensity × area of 
cell is subtracted to yield the CTI. (D2) Combing the statistical information and pixel order allows for complex analysis of 
the maps.  For example, from the map library (D1) the value of two and three standard deviations above the mean pixel 
intensity can be calculated. These values can be used to recolor the map (C) and visually the contrast between the 
background and region of interest (ROI) becomes evident. The data tool can also now distinguish the ROI from the 
background and determined the size of the ROI (E). 
 
baseline corrected and then normalized by the SERS intensity of the nanoprobes for that 214 
experiment. SERS maps, such as those in Figure 3D-F, were generated by selecting the spectral 215 
feature at 1609 cm-1 and plotting the intensity at each pixel. To compare maps and evaluate cell-216 
to-cell variability, a new parameter, corrected total intensity (CTI), was defined. This parameter, 217 
an analogue to corrected total cell fluorescence (CTCF)37,38, values pixel order and how the 218 
object of interest is distinct from the background. A benefit of SERS rastering is the collection of 219 
data with four dimensions (x location, y location, wavenumber, and intensity). In generating a 220 
map, the dimensionality of the data is reduced to three dimensions (x location, y location, and 221 
intensity at a specific wavenumber) and allows for intuitive visual inspection that is easily 222 
correlated to the mapped feature (i.e., a cell). However, in typical SERS analyses the x and y 223 
mapping data are disregarded and the discussion is focused on the statistical characterization of a 224 
spectral feature of interest.  While this approach may be appropriate for the mapping of 225 
homogenous samples, the study of biological samples demands that the x-y information, the 226 
ordering of the pixels, is taken into account during analysis. Fluorescence spectroscopy often 227 
deals with data in the three dimensions of x location, y location, and intensity and thus we 228 
adopted the corrected total cell fluorescence measurement to analyze SERS maps.  229 
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Figure 3. Optical images with a 20µm scale bar (A-C) of single PC3 cells encapsulated in droplets with the corresponding 
SERS maps with 5µm scale bar (D-F). The corrected total intensity (circles) and integrated dentistry (squares) for four 
different experiments, each represented in a unique color, with error bars representing one standard deviation (G). 
The CTI values were determined by calculating the integrated density, the mean image 237 
intensity multiplied by the area of interest, and subtracting the average background intensity. 238 
Standard CTCF analysis is performed using ImageJ. Within ImageJ a threshold is applied to an 239 
imported image to find the objects of interest and the integrated density is then calculated for 240 
those regions of interest. The intensity for the background is then determined in ImageJ and 241 
ultimately in Excel (or a program of choice) the CTCF is calculated by finding the difference 242 
between the mean intensity in the ROI and the background and multiplying that by the area of 243 
the ROI.  244 
Our CTI were calculated in ImageJ using the same protocol except the starting images 245 
were SERS maps generated from the data. To demonstrate the need for ROI selection, the CTI 246 
data is compared with the total map intensity, the sum of the intensity at every point in the map, 247 
or described differently the integrated density of the map without ROI selection Figure 3G.  248 
The coefficient of variation (CoV) was used to describe the variation across the collected 249 
data sets and the CTI results had a consistently larger CoV than the total map intensities (SI 250 
Table 2). In the total map calculations, the intensity contribution of the cell, which occupies 251 
~30% of the map area, was damped by the background pixels. To demonstrate that the variation 252 
in the nanoprobe attachment from to cell-to-cell was neither the product of the functionalization 253 
chemistry, nor the orientation of the cells during cell mapping, the experiment was replicated 254 
using WGA functionalized with the fluorophore fluorescein (FITC). Interestingly, when the 255 
coefficient of variation for the CTFC results were tabulated (SI Table 3) they fell in the same 256 
range, 0.4 and 0.6, as the CTI calculations.  The results show that there is indeed cell to cell 257 
variability in the expression of sialic acid residues on the surface of the PC3 cells.    258 
 259 
 260 
 
Figure 4. The size of all regions of interest (ROI), classified as a cluster of more than one pixel with an intensity greater 
than two standard deviations (2×) above the mean, for each experiment (A). Pie graph showing the distribution of ROI 
size (µm2) for the whole data set. Each wedge is labeled with the size range and the percentage of ROI in that wedge (B). 
 
In comparing the SERS maps, Figure 3D-F, and the fluorescence images, Figure S3, it 261 
was apparent that sialic acid residues were heterogeneously distributed on the cell surface, 262 
typically with a large cluster of glycans occurring in one area. To quantify the size of the glycan 263 
clusters the data processing tool was expanded for image processing.  Specifically, for each 264 
experiment the LUT was defined to be 2× to 3× the standard deviation above the mean intensity 265 
of the data set; this thresholding set the majority of the background (pixels) to black. Contrast 266 
aids the edge finding scripts to determine the boundary between the region of interest and the 267 
background. Pixels above the threshold were identified and only clusters containing more than 268 
one pixel were extracted from the maps to ensure that the SERS signal was arising from glycan 269 
locations and not noise. Furthermore, differences in the probe signal on the cell surface arise 270 
most likely from quantitative differences in the sialic acid and not from variation in probe size. 271 
Using the work of Haiss et al.39 to estimate surface plasmon resonance (SPR) of the probes 272 
(~135 nm diameter), the majority of the probes will have an SPR at 632 nm, in near perfect 273 
resonance with the 633 nm laser. Whereas, the SPR for larger probes will be at higher 274 
wavelengths and thus off-resonance and responsible for a smaller fraction of the signal.   275 
Maps could contain more than one cluster. The size of the clusters, in µm2, was 276 
determined and the cluster sizes on a per experiment basis plotted (Figure 4A). Most of the 277 
clusters, 53%, were smaller than 10 µm2 and given that the average PC3 cell is 20 µm in 278 
diameter and, modeling the cell simply as a sphere, most clusters cover less than 3% of the cell 279 
surface. Even the largest cluster at 84 µm2 occupies at max 27% of the area of an average cell. 280 
However, 47% of cells contain more than one glycan island suggesting that a direct area to area 281 
comparison would be more descriptive of glycan expression. 282 
To understand glycan surface coverage in more detail, for each cell the size of the glycan 283 
island(s) was compared to the cell area. The exposed cell area was calculated with the same edge 284 
finding scripts as the island area except that input figures were the optical images of the cells. 285 
The pie graph (Figure 4B) underscores that most of the cells, 66%, had less than 20% of their 286 
total exposed area covered by glycans. Returning to the largest cluster, it was found to be the 287 
only island on that specific cell, the largest island in the dataset, covered 30% of the area of the 288 
cell; extremely close to the initial estimate. The largest total glycan area was 111 µm2, originating 289 
from two islands, and covering 43% of the cell area whereas the cell with greatest coverage, 290 
48%, contained a total glycan area of 74 µm2. The fact that the largest single island, largest total 291 
glycan area, and largest area coverage are found on three different cells underscores that cell-to-cell 292 
variability exists and that measuring the differences becomes accessible with the implementation of SERS 293 
droplet microfluidics. Moreover, the identification of these heterogeneities on the cell surface prompted 294 
biological experiments.   295 
Imaging Across Scales. 296 
A major benefit of using SERS droplet microfluidics is the ability to examine many different 297 
cells at once. Typically, as done for whole cell imaging, regions of interest are manually 298 
identified under white light and then SERS mapping areas are defined. The process of visually 299 
identifying regions of interest is laborious and time consuming especially when compared with 300 
fluorescent image collection, such as those in Figure S3, where hundreds of cells can be imaged 301 
quickly. Furthermore, the ability to identify SERS ROI’s without first using the white light 302 
image is advantageous because it removes the reliance on the white light microscope and pushes 303 
towards fully automated application.  Figure 5 shows the potential of SERS detection at scale 304 
with panel B showing a SERS map of a 760 µm by 760 µm region, taken at a relatively low 305 
resolution (20µm/pixel). An area of interest was identified and mapped at higher resolution 306 
(5µm/pixel), panel C, and the map clearly showed the presence of a cell. A bright field image 307 
was then collected and confirmed the presence of a cell. A more detailed map, such as that in the 308 
single cell experiments could also have been easily collected if so desired 309 
SERS at scale presents many exciting capabilities and has the ability to increase the 310 
applicability of SERS for biological studies. The ability to survey over 1000 droplets rapidly 311 
increases the quantification accessible with SERS for both lab based studies and the production 312 
of point-of-care sensors. Rapid SERS screening will allow the method to compete with more 313 
standard techniques such as flow cytometry, but introduce the ability to easily identify and map 314 
with high resolution cells of interest. The platform is well suited for the study of environmental 315 
samples that are typically sample limited and/or highly dilute. An automated platform will aid in 316 
the identification of targets of interest without destroying the sample thus allowing SERS to be 317 
combined with more traditional analyses such as culturing or genomics analysis.  Another major 318 
benefit of using SERS at scale is the ability to study dynamic processes. Unlike, fixed cell 319 
 
Figure 5. Schematic of the optofluidic platform (A) followed by the SERS at scale process. Note that the orange box in A 
denotes the SERS mapping shown in B. The processed low-resolution SERS map is shown in B with an area of interested 
outlined with a blue box. The area of interest is than scanned with higher resolution (C) and a second region of interest, the 
cell, is circled in green. The white light image of the area, orange box, is collected and then two regions of interest, blue box 
and green circle, are used to confirm the accurate identification of the cell.  
experiments or -omics analyses, the optofluidic platform allows for the study of cellular behavior 320 
as a function of time. With slight modifications to the platform, stressors can be introduced into 321 
the droplets and SERS can be used to measure changes in the behavior of individual cells, 322 
opposed to traditional measurements which look at changes in bulk population behavior.  323 
Conclusion and Future Outlook.  324 
SERS droplet microfluidics is a powerful tool for single-cell analysis and the imaging of aqueous 325 
systems of biological importance.  In this paper, we have used this technology to show cell-to-326 
cell variation in glycan surface coverage, created a centralized data processing tool and showed 327 
the ability to access cellular information at a range of scales. The methods and tools presented 328 
herein lay the foundation for future SERS studies and show the first application of the platform 329 
for deciphering the composition of cell membranes. Multiplex SERS assays can be deployed in a 330 
droplet microfluidic device without any modification to the methods described. Moreover, the 331 
use of image processing to interpret SERS maps can be adopted for other applications where the 332 
region of interest is only a subset of the total area mapped.  333 
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